Prospective cohort study links NETosis markers to postoperative frailty in advanced ovarian cancer patientsDo blood markers predict weakness after ovarian cancer surgery?

This prospective cohort study included 189 advanced ovarian cancer patients. The investigation aimed to evaluate the relationship between neutrophil extracellular trap markers and postoperative frailty. Participants were categorized into frail and non-frail groups for comparison. The follow-up duration was 2 years. No specific study location was reported in the text.

The exposure assessed included key neutrophil extracellular trap markers: neutrophil elastase, myeloperoxidase, and citrullinated histone H3. The comparator consisted of frail versus non-frail groups. Absolute numbers indicated 41 patients were frail and 148 were non-frail. Significant differences were found between groups in neutrophil elastase, myeloperoxidase, and citrullinated histone H3. P values were reported as significant, but specific values were not provided in the text.

Secondary outcomes included age, education, marital status, daily activity, nutrition score, State-Trait Anxiety Inventory (STAI), and Pittsburgh Sleep Quality Index (PSQI). Significant differences were found between groups for all secondary outcomes listed. Safety data regarding adverse events, serious adverse events, and discontinuations were not reported. Tolerability information was also not reported.

Key limitations were not reported in the provided text. Practice relevance was not reported. The study type does not support causal inference. Clinicians should recognize these findings as associations rather than established causal relationships. Further research is needed to confirm these observations in this population. The absence of specific p-values limits precise interpretation of the statistical significance.